Accelerating patient access to novel biologics using stable pool-derived product for non-clinical studies and single clone-derived product for clinical studies-Reference-Cited by-同舟云学术

Accelerating patient access to novel biologics using stable pool-derived product for non-clinical studies and single clone-derived product for clinical studies

Published:2017-11 Issue:6 Volume:33 Page:1476-1482
ISSN:8756-7938
Container-title:Biotechnology Progress
language:en
Short-container-title:Biotechnol Progress

Author:

Munro Trent P.¹^ORCID,Le Kim²,Le Huong²,Zhang Li²,Stevens Jennitte²,Soice Neil²,Benchaar Sabrina A.¹,Hong Robert W.¹,Goudar Chetan T.²

Affiliation:

1. Attribute Sciences, Process Development, Amgen Inc., 1 Amgen Center Drive; Thousand Oaks CA 91320

2. Drug Substance Technologies, Process Development, Amgen Inc., 1 Amgen Center Drive; Thousand Oaks CA 91320

Publisher

Wiley

Subject

Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/btpr.2572/fullpdf

Reference23 articles.

1. Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach;Eon-Duval;Biotechnol Progr.,2012

2. Production of recombinant protein therapeutics in cultivated mammalian cells;Wurm;Nat Biotechnol.,2004

3. Recent advances in mammalian protein production;Bandaranayake;FEBS Lett.,2014

4. Cell culture processes for monoclonal antibody production;Li;mAbs,2010

5. Recombinant protein therapeutics from CHO cells-20 years and counting;Jayapal;Chem Eng Progr.,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-attribute monitoring applications in biopharmaceutical analysis;Journal of Chromatography Open;2024-11

2. SiMPl‐GS: Advancing Cell Line Development via Synthetic Selection Marker for Next‐Generation Biopharmaceutical Production;Advanced Science;2024-08-06

3. Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool;Vaccines;2024-05-21

4. Further accelerating biologics development from DNA to IND: the journey from COVID-19 to non-COVID-19 programs;Antibody Therapeutics;2024-01

5. Recombinant CHO Cell Pool Generation Using PiggyBac Transposon System;Methods in Molecular Biology;2024